12 December 2024 in Quality in Sport
Type 2 diabetes (T2D) is a widespread and growing health problem globally, marked by hyperglycemia, insulin resistance, and serious metabolic complications. Numerous studies confirm the positive impact of physical activity on T2D management, with aerobic and resistance exercises proving particularly effective. This study aims to review the role of physical activity in glycemic control and metabolic health in T2D patients, considering guidelines from the American Diabetes Association, as well as various physiological and psychological barriers that may limit the effectiveness of exercise programs.
22 December 2024 in Quality in Sport
Postoperative scarring presents a significant challenge in sports medicine, particularly for athletes seeking a rapid return to intensive physical activity. This study aimed to evaluate the efficacy of laser therapy in improving the quality of postoperative scars and its impact on rehabilitation time. A cohort of competitive athletes aged 18–40 with hypertrophic scars resulting from orthopedic surgeries underwent five biweekly sessions of laser therapy using fractional CO2 and pulsed dye lasers (PDL). Scar assessment included the Vancouver Scar Scale (VSS) and Cutometer-based skin elasticity measurements, with additional evaluations of pain and functionality using the Visual Analog Scale (VAS). Fractional CO2 laser therapy significantly reduced VSS scores by 2.5 points and increased skin elasticity by 15%, while PDL therapy effectively decreased erythema by 30%. Athletes treated with laser therapy returned to high-intensity training an average of three weeks earlier than those receiving standard scar treatments. Side effects, such as transient redness and swelling, were mild and resolved within 2–3 days. These findings suggest that laser therapy, particularly fractional CO2 and PDL, is a safe and effective intervention for managing postoperative scars in athletes, enhancing both aesthetic and functional outcomes while accelerating rehabilitation timelines. Further research is recommended to optimize protocols and evaluate long-term benefits.
17 March 2026 in Journal of Education, Health and Sport
Background. Kratom (Mitragyna speciosa) use is increasing internationally and case reports describe a range of withdrawal syndromes. Clinical guidance for recognizing and managing kratom withdrawal is limited. This narrative review of case reports synthesizes clinical features, management strategies, and outcomes among published patient cases. Aim. To characterize the clinical features, management strategies, and outcomes reported in published cases of kratom withdrawal. Additionally, identify common patterns in presentation and treatment that may inform preliminary clinical guidance for recognition and management. Methods. Article databases were searched for case studies related to kratom withdrawal. After screening titles/abstracts and full texts, 12 reports describing 16 individual patients were included. Data was extracted and findings were narratively synthesized across demographics/use characteristics, clinical presentation, pharmacological management, and outcomes. Results. Reported reasons for kratom use included self-treatment of opioid use disorder, pain, and psychiatric symptoms. Presentation varied from mild autonomic and gastrointestinal symptoms to severe, atypical syndromes. Opioid-like features of mild severity relative to usual opioid use predominated. Pharmacological management most commonly involved buprenorphine/naloxone. Clonidine and benzodiazepines were common adjuncts. Conclusions. Case-level evidence and existing literature indicates that kratom withdrawal most often presents as an opioid-like syndrome and that buprenorphine, with symptom-driven, conservative induction, was the most consistently effective treatment in reported cases. Interpretation is limited by small numbers, heterogeneous and incomplete reporting (dose/formulation/duration). Prospective, standardized reporting of exposure and outcomes and kratom-specific validation of withdrawal assessment tools are needed to inform evidence-based management.